drugset / Trial / NCT00695071

Study to Assess Blood Levels of Itraconazole During a Two-Week Period

NCT00695071

Phase 1 Completed 16 enrolled Stiefel, a GSK Company GlaxoSmithKline · collab
NaSingle-groupOpen-label

Summary

The objective of this clinical trial is to document the steady state pharmacokinetics and safety of a new itraconazole 200 mg film coated tablet.

Timeline

Start
2008-06
Primary completion
2008-07
Completion
2008-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Itraconazole Small molecule 200 mg Oral

Indications

No indication recorded.